Palo Alto Investors LP United Therapeutics Corp Transaction History

Palo Alto Investors LP

$856 Million
Q1 2024

A detailed history of Palo Alto Investors LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Palo Alto Investors LP holds 267,759 shares of UTHR stock, worth $73.7 Million. This represents 7.19% of its overall portfolio holdings.

Number of Shares

267,759

Previous 395,784 32.35%

Holding current value

$73.7 Million

Previous $87 Million 29.32%

% of portfolio

7.19%

Previous 7.96%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $27 Million - $31.9 Million	-128,025 Reduced 32.35%	267,759 $61.5 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $38.7 Million - $46.3 Million	-180,123 Reduced 31.28%	395,784 $87 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $10.9 Million - $12.8 Million	-51,607 Reduced 8.22%	575,907 $130 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $447,279 - $579,957	2,100 Added 0.34%	627,514 $141 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $1.67 Million - $2.28 Million	-8,120 Reduced 1.28%	625,414 $174 Million

Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $258,597 - $310,584	-1,272 Reduced 0.2%	633,534 $133 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $3.19 Million - $4.41 Million	-18,273 Reduced 2.8%	634,806 $150 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $5.67 Million - $7.3 Million	-34,127 Reduced 4.97%	653,079 $117 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $15.1 Million - $17.2 Million	-98,200 Reduced 12.5%	687,206 $115 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $1.9 Million - $2.3 Million	19,000 Added 2.48%	785,406 $79.3 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $10.2 Million - $13.9 Million	-110,169 Reduced 12.57%	766,406 $92.7 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $32.7 Million - $47.6 Million	-412,327 Reduced 31.99%	876,575 $83.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $10.6 Million - $12.9 Million	-135,499 Reduced 9.51%	1,288,902 $114 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $9.61 Million - $11 Million	-128,391 Reduced 8.27%	1,424,401 $114 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $6.03 Million - $9.57 Million	-79,233 Reduced 4.85%	1,552,792 $121 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $688,607 - $874,205	6,791 Added 0.42%	1,632,025 $178 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $263,267 - $307,960	2,603 Added 0.16%	1,625,234 $184 Million
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $1.76 Million - $2.49 Million	16,381 Added 1.02%	1,622,631 $182 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $18.5 Million - $23.7 Million	-156,400 Reduced 8.87%	1,606,250 $238 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $202 Million - $241 Million	1,762,650	1,762,650 $207 Million

Others Institutions Holding UTHR

# of Institutions

562

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $12.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP United Therapeutics Corp Transaction History